harpoontx.com - HARP Income before deduction of interest, taxes and amortization
Harpoon Therapeutics develops cancer treatment methods via the TriTAC platform. The automation of antibody synthesis in laboratories accelerates drug release. Absolute operating profit reflects current cash flow dynamics, where represents the latest level value. The business valuation currently depends not on sales, but on the prospects of selling unique technologies through M&A transactions.
Harpoon Therapeutics, Inc. - analytical breakdowns and key metrics (HARP)
- market value and analyst target forecast:
- issuer market value details:
- book capitalization information:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Harpoon Therapeutics|HARP - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Harpoon Therapeutics Inc|HARP - Company Debts|Debt to Book Value Ratio Harpoon Therapeutics|HARP - Company Long-Term Debt|Short-Term Debt Harpoon Therapeutics|Critical Liquidity harpoontx.com
- company profitability and valuation multiples indicators:
HARP - Net Income|Future Net Profit Harpoon Therapeutics|HARP - P/E Multiple|Future Price to Earnings Multiple harpoontx.com|HARP - PEG Multiple|Company Value to EBITDA Harpoon Therapeutics|HARP - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Harpoon Therapeutics|HARP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth harpoontx.com|HARP - Earnings per share growth in current year|Net earnings per share change forecast for next year Harpoon Therapeutics
Analysis of all company metrics:Harpoon Therapeutics Corp - HARP
This metric reflects net cash flow from operating activities, excluding depreciation and accounting adjustments to assess real operational efficiency. By analyzing EBITDA, an investor can discern the business resilience of Harpoon Therapeutics (HARP) amid geopolitical barriers, which directly impact operating expense dynamics through biomaterial logistics disruptions and drug certification delays.
Competitors of Harpoon Therapeutics (HARP)
NantKwest (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (januxrx.com)|RCUS: Operating profit EBITDA|ZYME - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Tango Pharma|Operating profit before deduction of amortization Iovance Corp (IOVA)|Profit before payment of interest, taxes and amortization Immatics N.V. (IMTX)|Operating profit before deduction of amortization xencor.com XNCR|Compass Therapeutics, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Replimune Group Inc REPL|LYEL - Profit before payment of interest, taxes and amortization|IPHA (Innate Pharma S.A) - Operating profit before amortization|pyxisoncology.com (PYXS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Compugen (CGEN)|Operating profit before deduction of amortization IOBT|STRO - Operating profit before depreciation charges|Operating profit before deduction of amortization INKT (MiNK)|Company profit before taxes, interest and amortization HOWL|Operating profit EBITDA IMMX (Immix Biopharma)|Income before deduction of interest, taxes and amortization ALXO|Cue Biopharma, Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization PDS Biotechnology|sonnetbio.com (SONN) - Profit before payment of interest, taxes and amortization|MAIA Bio - Income before deduction of interest, taxes and amortization|LIMN (Liminatus Pharma) - Operating profit EBITDA|Operating profit EBITDA Lava Tx|Profit before payment of interest, taxes and amortization NextCure (NXTC)|LPTX: Profit before deduction of interest, taxes, depreciation and amortization|Intensity Therapeutics, Inc. - Operating profit before deduction of amortization|Sensei Biotherapeutics Inc (SNSE) - Profit before interest, taxes and amortization|Theriva Biologics, Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization GRTS (Gritstone bio, Inc.)|KA: Operating profit EBITDA|NexImmune Inc (NEXI) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Turnstone Biologics Corp|VCNX: Income before deduction of interest, taxes and amortization
